Evidence map›Paper›PMID 41432345›Full record

ArticleProtein science : a publication of the Protein Society2026

The structural heterogeneity of AKT autoinhibition.

Liang Xu, Meryem Eren, Jackson Weako, Hyunbum Jang, Ozlem Keskin, Attila Gursoy, Ruth Nussinov

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. How Functional Variants Reconfigure the Rac2 Conformational Landscape.bioRxiv : the preprint server for biology · 2026
    Article
  5. The structural heterogeneity of AKT autoinhibition.Protein science : a publication of the Protein Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liang XuComputational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, Maryland, USA.
Meryem ErenDepartment of Molecular Biology and Genetics, Koç University, Istanbul, Turkey.
Jackson WeakoComputational Science and Engineering Program, Koç University, Istanbul, Turkey.
Hyunbum JangComputational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, Maryland, USA.
Ozlem KeskinDepartment of Chemical and Biological Engineering, Koç University, Istanbul, Turkey.
Attila GursoyDepartment of Computer Engineering, Koç University, Istanbul, Turkey.
Ruth NussinovComputational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, Maryland, USA.ORCID https://orcid.org/0000-0002-8115-6415

Funding

Biomolecular Recognition and Binding MechanismsZIABC010441 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSINOV, RUTH · 2009 to 2025
$9.4M
Intramural NIH HHS ZIA BC010441NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INIH HHS HHSN261201500003I
6 · The paper itself

Abstract

AKT is key to controlling cell growth through the PI3K/AKT/mTOR pathway. In the cytosol, in the absence of stimulus, AKT is autoinhibited to prevent uncontrolled activation. Increased AKT activity contributes to tumor growth by phosphorylating numerous downstream targets. Relieving the autoinhibition is a prerequisite for full activation, which occurs through C-terminal tail phosphorylation by mTOR, followed by activation loop phosphorylation by PDK1. However, the atomic-level mechanisms by which AKT autoinhibition persists in the cytosol and the phosphorylation (posttranslational modifications) allosterically shift AKT to its open conformation, which may serve as drug targets, remain unclear. Here, we performed explicit molecular dynamics simulations to explore the conformational ensembles of AKT in these different states. Our unbiased results show how the variable loops of the PH domain contribute to the PH-mediated AKT autoinhibition. Autoinhibited states are commonly only marginally stable, populating function-related shallow metastable wells with relatively similar energies and low kinetic barriers, making them receptive to regulation. The conformational heterogeneity of AKT's autoinhibitory interface is susceptible to regulation, including by phosphorylation, but also by activating mutations and allosteric inhibitors. As to activation by phosphorylation, allosteric communication between the phosphorylated C-terminal tail and the PH domain of AKT promotes the release of the PH domain from the kinase domain, independent of PIP

Indexed as

Proto-Oncogene Proteins c-aktAllosteric RegulationHumansMolecular Dynamics SimulationPhosphorylationProtein ConformationProto-Oncogene Proteins c-aktAKTallostericautoinhibitionconformational ensembleconformational heterogeneitymutationphosphorylation

Identifiers

PMID41432345
PMCPMC12724016

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.